These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8394759)

  • 1. The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections.
    Mattie H
    Clin Investig; 1993 Jun; 71(6):480-2. PubMed ID: 8394759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Theoretical research for therapy of infection].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Aug; 43(8):815-23. PubMed ID: 1655924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of pharmacokinetic and pharmacodynamic parameters fro establishing the optimal dosage of antibacterials].
    Gomis Gavilán M; Prieto Prieto J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):104-12. PubMed ID: 7711116
    [No Abstract]   [Full Text] [Related]  

  • 4. Single daily dosing of aminoglycosides: a commentary.
    Rotschafer JC; Rybak MJ
    Ann Pharmacother; 1994 Jun; 28(6):797-801. PubMed ID: 7919572
    [No Abstract]   [Full Text] [Related]  

  • 5. [New methods of administration of cephalosporins and aminoglycosides: relations between pharmacokinetics and pharmacodynamics].
    Kamnev IuV
    Antibiot Khimioter; 1992 Feb; 37(2):44-50. PubMed ID: 1514855
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides.
    Gilbert DN
    Clin Infect Dis; 1997 May; 24(5):816-9. PubMed ID: 9142774
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing strategies in aminoglycoside dosing; the result of research on antimicrobial pharmacodynamics.
    Zhanel GG
    Zentralbl Bakteriol; 1993 Nov; 279(4):447-9. PubMed ID: 8305801
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intracellular pharmacokinetics and pharmacodynamics of antibiotics].
    Tulkens PM
    Rev Pneumol Clin; 1996; 52 Suppl 2():S51-5. PubMed ID: 9033918
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibacterial agents in the treatment of ocular infections.
    Barza M
    Infect Dis Clin North Am; 1989 Sep; 3(3):533-51. PubMed ID: 2671138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design.
    Ebert SC; Craig WA
    Infect Control Hosp Epidemiol; 1990 Jun; 11(6):319-26. PubMed ID: 2165081
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models.
    Dalhoff A; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):479-87. PubMed ID: 2226476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside].
    Mimoz O; Grollier G
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735
    [No Abstract]   [Full Text] [Related]  

  • 13. Macrolides: pharmacokinetics and pharmacodynamics.
    Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S17-23. PubMed ID: 11574190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics.
    Toutain PL; del Castillo JR; Bousquet-Mélou A
    Res Vet Sci; 2002 Oct; 73(2):105-14. PubMed ID: 12204627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.
    Drusano GL
    Scand J Infect Dis Suppl; 1990; 74():235-48. PubMed ID: 2097712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of bacterial infections in patients with kidney failure and hemodialysis].
    Yamasaku F
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1646-52. PubMed ID: 2079588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Factors affecting the pharmacokinetics of aminoglycoside antibiotics].
    Dyderski S
    Wiad Lek; 1989 Jul 1-15; 42(13-15):919-23. PubMed ID: 2634321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antimicrobial chemotherapy--its clinico-pharmacologic significance].
    Graber H
    Orv Hetil; 1989 Dec; 130(50):2671-5. PubMed ID: 2557571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
    Sanders CC; Watanakunakorn C
    J Infect Dis; 1986 Mar; 153(3):617-9. PubMed ID: 3512733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.